Amid battle over ethics, Biogen stands firm on denial of experimental ALS drug

A couple dozen people rallied in front of Biogen’s headquarters on Tuesday morning, and another 99,000 people have signed a petition online in support of Lisa Stockman-Mauriello, a 51-year-old New Jersey woman with a rapidly progressing form of amyotrophic lateral sclerosis, or ALS. Stockman-Mauriello’s doctor has requested that Biogen authorize an experimental ALS drug, tofersen,…

Read More

DraftKings acquires Las Vegas broadcaster VSiN

The online sports betting operator (Nasdaq: DKNG) did not say how much it paid to acquire Vegas Sports Information Network Inc., or VSiN, a Las Vegas-based developer, producer and distributor of up to about 18 hours of live linear sports betting content each day. Read More

Read More